La vendita allo scoperto per Ark Restaurants dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Ark Restaurants. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Ark Restaurants (NASDAQ:ARKR) Azioni, Report sulle vendite allo scoperto

Ark Restaurants

Ark Restaurants Corp owns and operates around 17 restaurants and bars, 16 fast food concepts, and catering operations in the USA. The Las Vegas operations include New York Hotel & Casino Resort, hotel room service operations, banquet facilities, employee dining room, food court concepts, and a restaurant within the Planet Hollywood Resort and Casino. It operates a restaurant and a bar in the Resorts Atlantic City Hotel and Casino and a restaurant in the Tropicana Hotel and Casino. The Florida operations include The Rustic Inn in Dania Beach, Shuckers in Jensen Beach, JB's on the Beach in Deerfield Beach, The Blue Moon Fish Company in Fort Lauderdale, and fast food facilities in Tampa and Hollywood. In Alabama, it operates Original Oyster Houses in Gulf Shores and Spanish Fort.

Ark Restaurants Corp

Ark Restaurants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKR#NASDAQ">ARKR</a>) reported quarterly earnings of $0.18 per share. This is a 79.55 percent decrease over earnings of $0.88 per share from the same period last year. The company reported $50.40 million in sales this quarter. This is a 1.28 percent decrease over sales of $51.05 million the same period last year.

Earnings

News

ARKR

Ark Restaurants Q3 GAAP EPS $0.18 Down From $0.88 YoY, Sales $50.40M Down From $51.05M YoY

WIIM

ABNB

DENN

KRUS

MODG

NCLH

PENN

SBUX

SPGC

STKS

TXRH

WING

WYNN

Shares of hotel, restaurant and leisure companies are trading lower amid overall market weakness on US economic concerns.

Although U.S. stocks closed lower on Thursday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#8217;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Turtle Beach</h3>
<ul>
<li>The Trade: Turtle Beach Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEAR#NASDAQ">HEAR</a>) Director Terry Jimenez <a href="https://www.benzinga.com/quote/HEAR/analyst-ratings">acquired a total of 2,025 shares</a> an average price of $16.37. To acquire these shares, it cost around $33,149.</li>
<li>What's Happening: On May 7, Turtle Beach posted better-than-expected quarterly earnings.</li>
<li>What Turtle Beach Does: Turtle Beach Corp specializes in gaming accessories, offering a diverse range including headsets, controllers, keyboards, mice, and simulation hardware.</li>
</ul>
<h3 class="wp-block-heading">Ark Restaurants</h3>
<ul>
<li>The Trade: Ark Restaurants Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKR#NASDAQ">ARKR</a>) 10% owner Thomas A Satterfield Jr acquired a total of 19,815 shares at an average price of $14.50. To acquire these shares, it cost around $287,020..</li>
<li>What's Happening: On May 13, Ark Restaurants posted a wider quarterly loss.</li>
<li>What Ark Restaurants Does: Ark Restaurants Corp owns and operates around 17 restaurants and bars, 16 fast food concepts, and catering operations in the USA.</li>
</ul>
Don&#8217;t forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<h3 class="wp-block-heading">iRobot</h3>
<ul>
<li>The Trade: iRobot Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRBT#NASDAQ">IRBT</a>) President and CEO Gary Cohen <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 2,050 shares</a> at an average price of $12.29. To acquire these shares, it cost around $25,189.</li>
<li>What's Happening: On May 7, iRobot reported better-than-expected first-quarter financial results.</li>
<li>What iRobot Does: iRobot Corp is a united state based consumer robot company.</li>
</ul>
<h3 class="wp-block-heading">First Financial Bankshares</h3>
<ul>
<li>The Trade: First Financial Bankshares, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIN#NASDAQ">FFIN</a>) EVP/CFO Michelle S Hickox <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 1,000 shares</a> at an average price of $31.25. The insider spent around $31,250 to buy those shares.</li>
<li>What's Happening: On April 18, First Finl Bankshares posted upbeat quarterly earnings.</li>
<li>What First Financial Bankshares Does: First Financial Bankshares Inc is a financial and bank holding company.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/24/05/38872018/top-5-utilities-stocks-you-may-want-to-dump-in-may">Top 5 Utilities Stocks You May Want To Dump In May</a>

Long Ideas

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

FFIN

HEAR

IRBT

Insiders Buying Turtle Beach And 3 Other Stocks

Ark Restaurants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKR#NASDAQ">ARKR</a>) reported quarterly losses of $(0.40) per share. This is a 207.69 percent decrease over losses of $(0.13) per share from the same period last year. The company reported $42.26 million in sales this quarter. This is a 0.86 percent increase over sales of $41.90 million the same period last year.

Ark Restaurants Q2 EPS $(0.40) Down From $(0.13) YoY, Sales $42.26M Up From $41.90M YoY

Ark Restaurants Q1 2024 EPS $0.38 Down From $0.47 YoY; Revenue $47.487M Up From $$47.445M YoY

Ark Restaurants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKR#NASDAQ">ARKR</a>) reported quarterly losses of $(2.88) per share. This is a 1471.43 percent decrease over earnings of $0.21 per share from the same period last year. The company reported $44.40 million in sales this quarter. This is a 5.30 percent decrease over sales of $46.88 million the same period last year.

Ark Restaurants Q4 EPS $(2.88) Down From $0.21 YoY, Sales $44.40M Down From $46.88M YoY

<h3>&nbsp;</h3>
<h3>Companies Reporting After The Bell</h3>
&bull; Heico (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HEI#NYSE">HEI</a>) is estimated to report quarterly earnings at $0.69 per share on revenue of $898.25 million.
&bull; GEE Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/JOB#AMEX">JOB</a>) is projected to report quarterly earnings at $0.00 per share on revenue of $40.35 million.
&bull; Ark Restaurants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKR#NASDAQ">ARKR</a>) is estimated to report earnings for its fourth quarter.
&bull; Quipt Home Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QIPT#NASDAQ">QIPT</a>) is likely to report earnings for its fourth quarter.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

QIPT

Earnings Scheduled For December 18, 2023

Ark Restaurants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKR#NASDAQ">ARKR</a>) reported quarterly earnings of $0.88 per share. This is a 39.73 percent decrease over earnings of $1.46 per share from the same period last year. The company reported $51.05 million in sales this quarter. This is a 4.07 percent decrease over sales of $53.22 million the same period last year.

Ark Restaurants Q3 EPS $0.88 Down From $1.46 YoY, Sales $51.05M Down From $53.22M YoY

<h3>What Defines a Value Stock?</h3>
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock. 
<h2>Benzinga Insights has compiled a list of value stocks in the consumer cyclical sector that may be worth watching:</h2>
<ol>
<li>Torrid Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CURV#NYSE">CURV</a>) - P/E: 7.58</li>
<li>KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) - P/E: 6.31</li>
<li>Chico's FAS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHS#NYSE">CHS</a>) - P/E: 6.54</li>
<li>Virco Mfg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRC#NASDAQ">VIRC</a>) - P/E: 3.58</li>
<li>Ark Restaurants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKR#NASDAQ">ARKR</a>) - P/E: 8.82</li>
</ol>
Torrid Holdings's earnings per share for Q1 sits at $0.11, whereas in Q4, they were at -0.04. KB Home's earnings per share for Q2 sits at $1.94, whereas in Q1, they were at 1.45. Most recently, the company reported a dividend yield of 1.51%, which has increased by 0.04% from last quarter's yield of 1.47%.
Chico's FAS's earnings per share for Q1 sits at $0.32, whereas in Q4, they were at 0.06. Most recently, the company reported a dividend yield of 9.21%, which has increased by 0.84% from last quarter's yield of 8.37%.
Virco Mfg saw a decrease in earnings per share from 0.25 in Q4 to $-0.09 now. The company's most recent dividend yield sits at 1.4%, which has decreased by 0.06% from 1.46% last quarter. 
Ark Restaurants saw a decrease in earnings per share from 0.47 in Q1 to $-0.13 now. The company's most recent dividend yield sits at 4.28%, which has increased by 1.76% from 2.52% last quarter. 
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.

CURV

VIRC

Overview Of Value Stocks In The Consumer Cyclical Sector

Ark Restaurants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKR#NASDAQ">ARKR</a>) reported quarterly losses of $(0.13) per share. This is a 144.83 percent decrease over earnings of $0.29 per share from the same period last year. The company reported $41.90 million in sales this quarter. This is a 5.84 percent increase over sales of $39.59 million the same period last year.

Ark Restaurants Q2 EPS $(0.13) Down From $0.29 YoY, Sales $41.90M Up From $39.59M YoY

<h3>Gainers</h3>
<ul>
<li>a.k.a. Brands Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AKA#NYSE">AKA</a>) shares rose 34.7% to $0.55 during Wednesday's pre-market session. The market value of their outstanding shares is at $70.7 million. </li>
<li>Bed Bath &amp; Beyond (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBBY#NASDAQ">BBBY</a>) stock increased by 27.58% to $0.44. The market value of their outstanding shares is at $187.3 million. </li>
<li>Ark Restaurants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKR#NASDAQ">ARKR</a>) shares increased by 7.4% to $19.0. The company's market cap stands at $68.4 million. </li>
<li>Amesite (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMST#NASDAQ">AMST</a>) stock moved upwards by 5.0% to $3.99. The company's market cap stands at $10.1 million. </li>
<li>MGO Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGOL#NASDAQ">MGOL</a>) shares moved upwards by 4.85% to $1.08. The market value of their outstanding shares is at $15.3 million. </li>
<li>Golden Sun Education Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSUN#NASDAQ">GSUN</a>) stock rose 4.83% to $1.3. The market value of their outstanding shares is at $23.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Unique Fabricating (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UFAB#AMEX">UFAB</a>) stock declined by 20.8% to $0.2 during Wednesday's pre-market session. The company's market cap stands at $2.3 million. </li>
<li>XPeng (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) stock declined by 6.74% to $10.52. The market value of their outstanding shares is at $9.0 billion. </li>
<li>PARTS iD (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ID#AMEX">ID</a>) shares fell 6.7% to $0.28. The market value of their outstanding shares is at $9.5 million. As per the press release, Q4 earnings came out 2 days ago. </li>
<li>Inspirato (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPO#NASDAQ">ISPO</a>) stock declined by 6.49% to $0.86. The market value of their outstanding shares is at $57.3 million. </li>
<li>Lithia Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAD#NYSE">LAD</a>) shares fell 6.39% to $212.0. The market value of their outstanding shares is at $5.8 billion. As per the press release, Q1 earnings came out today. </li>
<li>Lindblad Expeditions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIND#NASDAQ">LIND</a>) shares decreased by 5.45% to $10.77. The market value of their outstanding shares is at $572.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AMST

BBBY

GSUN

ISPO

LIND

MGOL

UFAB

XPEV

12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session

Ark Restaurants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKR#NASDAQ">ARKR</a>) reported quarterly earnings of $0.47 per share. This is a 22.95 percent decrease over earnings of $0.61 per share from the same period last year. The company reported $47.45 million in sales this quarter. This is a 7.86 percent increase over sales of $43.99 million the same period last year.

Ark Restaurants Q1 EPS $0.47 Down From $0.61 YoY, Sales $47.45M Up From $43.99M YoY

<h3>Companies Reporting Before The Bell</h3>
&bull; EuroDry (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDRY#NASDAQ">EDRY</a>) is expected to report quarterly earnings at $2.68 per share on revenue of $21.20 million.
&bull; Check Point Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHKP#NASDAQ">CHKP</a>) is projected to report quarterly earnings at $2.19 per share on revenue of $593.03 million.
&bull; Teradata (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDC#NYSE">TDC</a>) is estimated to report quarterly earnings at $0.30 per share on revenue of $436.27 million.
&bull; Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) is projected to report quarterly earnings at $0.12 per share on revenue of $3.89 billion.
&bull; Roivant Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROIV#NASDAQ">ROIV</a>) is expected to report quarterly loss at $0.39 per share on revenue of $14.64 million.
&bull; S&amp;W Seed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANW#NASDAQ">SANW</a>) is likely to report quarterly loss at $0.12 per share on revenue of $11.65 million.
&bull; Jerash Holdings (US) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JRSH#NASDAQ">JRSH</a>) is projected to report quarterly earnings at $0.09 per share on revenue of $34.00 million.
&bull; Dingdong (Cayman) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDL#NYSE">DDL</a>) is estimated to report earnings for its fourth quarter.
&bull; Monday.Com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) is projected to report quarterly loss at $0.37 per share on revenue of $141.23 million.
&bull; Blue Owl Cap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OWL#NYSE">OWL</a>) is expected to report quarterly earnings at $0.15 per share on revenue of $377.49 million.
&bull; Alexander&#39;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALX#NYSE">ALX</a>) is likely to report earnings for its fourth quarter.
&bull; Treehouse Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THS#NYSE">THS</a>) is estimated to report quarterly earnings at $0.92 per share on revenue of $1.02 billion.
<h3>Companies Reporting After The Bell</h3>
&bull; Brixmor Property Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRX#NYSE">BRX</a>) is likely to report quarterly earnings at $0.20 per share on revenue of $310.58 million.
&bull; Avis Budget Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAR#NASDAQ">CAR</a>) is likely to report quarterly earnings at $6.79 per share on revenue of $2.69 billion.
&bull; SolarEdge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) is estimated to report quarterly earnings at $1.55 per share on revenue of $879.23 million.
&bull; MKS Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKSI#NASDAQ">MKSI</a>) is likely to report quarterly earnings at $1.34 per share on revenue of $994.02 million.
&bull; Arch Capital Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACGL#NASDAQ">ACGL</a>) is projected to report quarterly earnings at $1.34 per share on revenue of $2.39 billion.
&bull; Eversource Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ES#NYSE">ES</a>) is likely to report quarterly earnings at $0.94 per share on revenue of $1.91 billion.
&bull; Cadence Design Sys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNS#NASDAQ">CDNS</a>) is expected to report quarterly earnings at $0.92 per share on revenue of $884.83 million.
&bull; MRC Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRC#NYSE">MRC</a>) is expected to report quarterly earnings at $0.28 per share on revenue of $872.20 million.
&bull; Quipt Home Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QIPT#NASDAQ">QIPT</a>) is estimated to report quarterly earnings at $0.04 per share on revenue of $42.18 million.
&bull; Outset Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OM#NASDAQ">OM</a>) is estimated to report quarterly loss at $0.86 per share on revenue of $30.92 million.
&bull; IAC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAC#NASDAQ">IAC</a>) is expected to report quarterly loss at $0.27 per share on revenue of $1.26 billion.
&bull; Kite Realty Gr Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRG#NYSE">KRG</a>) is expected to report earnings for its fourth quarter.
&bull; Angi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGI#NASDAQ">ANGI</a>) is estimated to report quarterly loss at $0.04 per share on revenue of $444.99 million.
&bull; Inotiv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NOTV#NASDAQ">NOTV</a>) is likely to report quarterly loss at $1.30 per share on revenue of $118.75 million.
&bull; Algoma Steel Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTL#NASDAQ">ASTL</a>) is expected to report quarterly loss at $0.46 per share on revenue of $510.22 million.
&bull; iRobot (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRBT#NASDAQ">IRBT</a>) is likely to report quarterly earnings at $0.20 per share on revenue of $379.14 million.
&bull; Ark Restaurants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKR#NASDAQ">ARKR</a>) is expected to report earnings for its first quarter.
&bull; Intercorp Financial Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IFS#NYSE">IFS</a>) is estimated to report quarterly earnings at $1.03 per share on revenue of $369.00 million.
&bull; Aethlon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEMD#NASDAQ">AEMD</a>) is likely to report quarterly loss at $0.17 per share on revenue of $10 thousand.
&bull; cbdMD (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) is expected to report earnings for its first quarter.
&bull; Vitesse Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTS#NYSE">VTS</a>) is projected to report earnings for its fourth quarter.
&bull; SkyWater Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>) is projected to report quarterly loss at $0.11 per share on revenue of $55.50 million.
&bull; Vicarious Surgical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBOT#NYSE">RBOT</a>) is likely to report earnings for its fourth quarter.
&bull; James Hardie Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JHX#NYSE">JHX</a>) is projected to report earnings for its third quarter.
&bull; Blackbaud (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLKB#NASDAQ">BLKB</a>) is expected to report quarterly earnings at $0.60 per share on revenue of $278.20 million.
&bull; Capstone Green Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGRN#NASDAQ">CGRN</a>) is projected to report quarterly loss at $0.18 per share on revenue of $22.50 million.
&bull; Vornado Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNO#NYSE">VNO</a>) is estimated to report earnings for its fourth quarter.
&bull; Investcorp Credit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICMB#NASDAQ">ICMB</a>) is likely to report quarterly earnings at $0.16 per share on revenue of $6.45 million.
&bull; Palantir Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) is estimated to report quarterly earnings at $0.03 per share on revenue of $502.25 million.
&bull; Bank of N.T Butterfield (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTB#NYSE">NTB</a>) is projected to report earnings for its fourth quarter.
&bull; Instructure Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INST#NYSE">INST</a>) is expected to report quarterly earnings at $0.26 per share on revenue of $121.45 million.
&bull; Otter Tail (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTTR#NASDAQ">OTTR</a>) is projected to report quarterly earnings at $0.84 per share on revenue of $316.60 million.
&bull; Amkor Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) is estimated to report quarterly earnings at $0.70 per share on revenue of $1.85 billion.
&bull; Seven Hills Realty Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEVN#NASDAQ">SEVN</a>) is expected to report quarterly earnings at $0.27 per share on revenue of $8.01 million.
&bull; Lattice Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) is projected to report quarterly earnings at $0.48 per share on revenue of $175.17 million.
&bull; Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) is estimated to report quarterly earnings at $1.21 per share on revenue of $1.20 billion.
&bull; Medpace Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>) is projected to report quarterly earnings at $1.79 per share on revenue of $386.01 million.
&bull; Denny&#39;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DENN#NASDAQ">DENN</a>) is estimated to report quarterly earnings at $0.16 per share on revenue of $120.45 million.
&bull; Albany Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIN#NYSE">AIN</a>) is expected to report quarterly earnings at $0.67 per share on revenue of $242.33 million.
&bull; FirstEnergy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FE#NYSE">FE</a>) is expected to report quarterly earnings at $0.52 per share on revenue of $2.54 billion.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

ACGL

AEMD

AMKR

ANET

ANGI

ASTL

BLKB

CDNS

CGRN

CHKP

EDRY

ICMB

INST

JRSH

LSCC

MEDP

MKSI

MNDY

NOTV

OTTR

PLTR

RBOT

ROIV

SANW

SEDG

SEVN

SKYT

YCBD

Earnings Scheduled For February 13, 2023

Small-cap stocks have long been valued by <a href="https://www.benzinga.com/news/23/01/30340173/exclusive-top-10-most-searched-tickers-on-benzinga-pro-in-2022-where-do-spy-tesla-apple-and-amc-rank">savvy investors</a> who understand that allocating to a less-efficient market segment can improve a portfolio&#39;s risk/return profile.
The same and more can be said about so-called micro caps &mdash; the low market cap segment that active traders tend to avoid. &quot;Sebastian,&quot; an anonymous micro-cap stock investor and enthusiast who is active on <a href="https://substack.com/profile/46690950-sebastian">Substack</a> and <a href="https://twitter.com/SebKrog">Twitter</a>, has been doing research on four microcap restaurant stocks that are trading at potentially attractive values.
<ul>
<li>Ark Restaurants Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arkr#NASDAQ">ARKR</a>) through its subsidiaries, owns and operates 17 restaurants and bars across the U.S. The company&rsquo;s market cap is $60.4 million. The lands it owns are worth roughly $25 million, Sebastian says. It also owns 8% of Meadowlands Racetrack in New Jersey, which will potentially be awarded a casino license. If Meadowlands receives a casino license, the revenues generated could be worth more than Ark&rsquo;s entire market cap.</li>
<li>Good Times Restaurants Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gtim#NASDAQ">GTIM</a>) is a regional chain of quick-service restaurants located primarily in Colorado. It owns two concepts: Good Times Drive Thru and Bad Daddy&rsquo;s Burger Bar. The company&rsquo;s market cap is $30.5 million, and it currently has a $5 million share buyback program in place.</li>
<li>Tortilla Mexican Grill PLC (LON: MEX), with a market cap of &pound;40.60 million ($49.3 million), operates and manages Mexican restaurants under the Tortilla brand. The company recently announced that it was highly resilient throughout 2022 despite ongoing macro headwinds. It claims revenues rose 20% year-over-year to &pound;57.7m ($70.1 million), driven by the ongoing strength of its customer proposition and demand for its sector-leading brands, as well as the continued expansion of its site portfolio.</li>
<li>Flanigan&#39;s Enterprises, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bdl#NYSE">BDL</a>) operates as a chain of small cocktail lounges and packaged&nbsp;liquor stores throughout Florida. It has a market cap of $50.9 million, with $32 million in cash on its balance sheet. The stock is currently trading around a 52-week low.</li>
</ul>
Benzinga&#39;s Take: Readers should understand that there&#39;s a significant risk in trading any stock, let alone ones that have a market cap below $100 million. Therefore, there&#39;s a need for careful in-depth research. 
Read next:&nbsp;<a href="https://www.benzinga.com/etfs/sector-etfs/23/01/30380003/airline-stocks-are-rallying-in-2023-even-with-travel-chaos-what-happens-next">Airline Stocks Are Rallying In 2023, Even With Travel Chaos: What Happens Next?</a>

Entertainment

Penny Stocks

Topics

Restaurants

Small Cap

General

GTIM

4 Sizzling Restaurant Stocks: Analyst Touts Recipe For Success With These Top Picks

<h3>Gainers</h3>
<ul>
<li>IceCure Medical Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iccm#NASDAQ">ICCM</a>) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who cannot be offered kidney-preserving surgery.</li>
<li>Avaya Holdings Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/avya#NYSE">AVYA</a>) gained 57% to $0.2384.</li>
<li>Athenex, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atnx#NASDAQ">ATNX</a>) surged 47% to $0.1991 after the company announced Quantum Leap Healthcare Collaborative reported a trial result of I-SPY2 trial for oral paclitaxel in combination with PD-1 and carboplatin in neoadjuvant breast cancer.</li>
<li>Verona Pharma plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrna#NASDAQ">VRNA</a>) shares climbed 40.5% to $18.71 after the company announced ensifentrine met primary and key secondary endpoints in the Phase 3 ENHANCE-1 trial for COPD.</li>
<li>Vallon Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vlon#NASDAQ">VLON</a>) shares climbed 33.9% to $0.4194. Vallon Pharmaceuticals and GRI Bio recently announced they entered into a merger agreement.</li>
<li>Dragonfly Energy Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dfli#NASDAQ">DFLI</a>) surged 29.7% to $25.95.</li>
<li>IAMGOLD Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iag#NYSE">IAG</a>) gained 26.9% to $2.31 after the company announced a transaction with Sumimoto Metal Mining to provide up to $340 million in additional funding to the contruction of the C&ocirc;t&eacute; Gold Project. Also, the company announced an agreement to sell its Boto Gold Project and surrounding exploration assets to Managem for a total consideration of $282 million.</li>
<li>United Insurance Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uihc#NASDAQ">UIHC</a>) gained 24.7% to $0.6256. United Insurance Holdings Chief Operating Officer Christopher Griffith bought a total of 20,000 shares at an average price of $0.57.</li>
<li>Acasti Pharma Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acst#NASDAQ">ACST</a>) jumped 22.5% to $0.4899.</li>
<li>Alset Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aei#NASDAQ">AEI</a>) jumped 22% to $0.1849.</li>
<li>Core Scientific, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/corz#NASDAQ">CORZ</a>) gained 21.7% to $0.2463.</li>
<li>Baudax Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bxrx#NASDAQ">BXRX</a>) rose 20.7% to $2.22. Baudax Bio recently announced initiation of a Phase II clinical trial evaluationg BX1000 in patients undergoing surgery.</li>
<li>Smart for Life, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smfl#NASDAQ">SMFL</a>) rose 20.5% to $0.2415 after dropping 22% on Monday.</li>
<li>Exicure, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xcur#NASDAQ">XCUR</a>) shares gained 18.9% to $0.88. Exicure 10% owner CBI USA, Inc. acquired a total of 3,400,000 shares at an average price of $1.60.</li>
<li>Appreciate Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sfr#NASDAQ">SFR</a>) gained 18.4% to $1.48.</li>
<li>MediaAlpha, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/max#NYSE">MAX</a>) gained 17.5% to $18.71. JP Morgan upgraded MediaAlpha from Neutral to Overweight and raised the price target from $12 to $14.</li>
<li>Pagaya Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pgy#NASDAQ">PGY</a>) rose 17.2% to $0.6705.</li>
<li>EverQuote, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ever#NASDAQ">EVER</a>) shares climbed 15.4% to $18.71 after JPMorgan upgraded the stock from Underweight to Overweight and raised its price target from $8 to $15.</li>
<li>Hycroft Mining Holding Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hymc#NASDAQ">HYMC</a>) gained 15.2% to $0.5245.</li>
<li>Taseko Mines Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tgb#NYSE">TGB</a>) gained 14.8% to $1.4358 after the company announced it formed a strategic partnershi with Mitsui to develop the company&#39;s Florence Copper project.</li>
<li>Surrozen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srzn#NASDAQ">SRZN</a>) rose 14.5% to $0.55 after gaining 8% on Monday.</li>
<li>Mitsubishi UFJ Financial Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mufg#NYSE">MUFG</a>) rose 14.3% to $6.34.</li>
<li>Landos Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/labp#NASDAQ">LABP</a>) gained 14.3% to $0.4710.</li>
<li>DLocal Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dlo#NASDAQ">DLO</a>) gained 14% to $15.03 after the company refuted a short-seller report and announced a share buyback program and proposed share purchases by key share holders.</li>
<li>Metacrine, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtcr#NASDAQ">MTCR</a>) rose 13.6% to $0.3980. Tang Capital Partners reported in 13G filing a 7.1% stake in Metacrine.</li>
<li>Natura &amp;Co Holding S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ntco#NYSE">NTCO</a>) gained 12.6% to $4.37.</li>
<li>Sumitomo Mitsui Financial Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smfg#NYSE">SMFG</a>) rose 12.2% to $7.70.</li>
<li>Gol Linhas A&eacute;reas Inteligentes S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gol#NYSE">GOL</a>) gained 11.7% to $2.68.</li>
<li>Steelcase Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/scs#NYSE">SCS</a>) gained 11.6% to $6.98 after the company announced better-than-expected Q3 EPS results.</li>
<li>New Pacific Metals Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/newp#NYSE">NEWP</a>) jumped 11.4% to $2.4350.</li>
<li>Vivos Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vvos#NASDAQ">VVOS</a>) gained 11.3% to $0.5475.</li>
<li>TAL Education Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tal#NYSE">TAL</a>) rose 11.3% to $9.02.</li>
<li>Coeur Mining, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cde#NYSE">CDE</a>) gained 8.7% to $3.41.</li>
</ul>
<h3>
Losers</h3>
<ul>
<li>Caravelle International Group (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/caco#NASDAQ">CACO</a>) shares dipped 57.9% to $2.03 after declining over 12% on Monday.</li>
<li>Magenta Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgta#NASDAQ">MGTA</a>) dropped 44% to $0.4650 after the company reported it stopped dosing participants at the Cohort 4 dosing level and plans to dose additional participants at the Cohort 3 dosing level due to dose-limiting toxicities.</li>
<li>Entrada Therapeutics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trda#NASDAQ">TRDA</a>) fell 33.5% to $13.22 after the company said it received a clinical hold notice from the FDA regarding its Investigational New Drug Application for ENTR-601-44 for the potential treatment of Duchenne muscular dystrophy.</li>
<li>Axcella Health Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axla#NASDAQ">AXLA</a>) shares fell 29.1% to $0.3048 after gaining 165% on Monday. Axcella Health recently announced organizational and program updates, including a reprioritization of its programs for Long COVID Fatigue and Nonalcoholic Steatohepatitis (NASH) and a restructuring of operations.</li>
<li>Arcus Biosciences, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rcus#NYSE">RCUS</a>) fell 28.1% to $21.92. Gilead Sciences and Arcus Biosciences announced results from the fourth interim analysis of the ARC-7 Phase 2 study for metastatic non-small cell lung cancer with PD-L1 tumor proportion score &ge;50% without epidermal growth factor receptor or anaplastic lymphoma kinase mutations.</li>
<li>BioVie Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bivi#NASDAQ">BIVI</a>) fell 27% to $7.27.</li>
<li>Soleno Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slno#NASDAQ">SLNO</a>) shares fell 26.3% to $1.3599. Soleno Therapeutics shares jumped around 104% on Monday after the company announced a financing commitment for up to $60 million..</li>
<li>AppTech Payments Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apcx#NASDAQ">APCX</a>) fell 24.4% to $1.0583 after jumping 55% on Monday.</li>
<li>Kineta Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ka#NASDAQ">KA</a>) fell 24.4% to $3.76.</li>
<li>Cosmos Health Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cosm#NASDAQ">COSM</a>) dropped 22% to $5.91. Cosmos Health recently announced pricing of a $32.5 million registered direct offering and concurrent private placement priced at-the-market.</li>
<li>Prenetics Global Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pre#NASDAQ">PRE</a>) fell 20.4% to $1.91.</li>
<li>Camber Energy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cei#NYSE">CEI</a>) fell 20% to $0.0857. Camber Energy shares jumped 73% on Monday after the company announced an anticipated effective date of December 21, 2022 for its previously-announced 1-for-50 reverse stock split.</li>
<li>Crown ElectroKinetics Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crkn#NASDAQ">CRKN</a>) fell 18.2% to $0.1451 after dropping 13% on Monday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.</li>
<li>Agrify Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agfy#NASDAQ">AGFY</a>) dropped 17.8% to $0.2750.</li>
<li>NantHealth, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nh#NASDAQ">NH</a>) shares fell 17.4% to $3.4801 after dropping 26% on Monday. NantHealth recently announced a 1-for-15 reverse stock split.</li>
<li>WaveDancer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wavd#NASDAQ">WAVD</a>) dipped 15.7% to $0.3975.</li>
<li>Duos Technologies Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/duot#NASDAQ">DUOT</a>) dropped 14.9% to $2.05.</li>
<li>Embecta Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/embc#NASDAQ">EMBC</a>) fell 14.8% to $27.65 after the company reported a decline in Q4 sales.</li>
<li>Vigil Neuroscience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vigl#NASDAQ">VIGL</a>) dropped 14.5% to $10.51.</li>
<li>MicroAlgo Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mlgo#NASDAQ">MLGO</a>) declined 14.3% to $1.44.</li>
<li>Mullen Automotive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/muln#NASDAQ">MULN</a>) fell 14.1% to $0.2330.</li>
<li>Leju Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/leju#NYSE">LEJU</a>) dropped 13.5% to $1.35.</li>
<li>Allarity Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/allr#NASDAQ">ALLR</a>) fell 13.4% to $0.3031.</li>
<li>Ark Restaurants Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arkr#NASDAQ">ARKR</a>) dropped 13.1% to $15.74 after the company reported a sharp decline in quarterly earnings.</li>
<li>Embecta Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/embc#NASDAQ">EMBC</a>) fell 12.4% to $28.47 after the company reported Q4 earnings results.</li>
<li>ioneer Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ionr#NASDAQ">IONR</a>) dropped 12.3% to $11.96.</li>
<li>Reed&#39;s, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/reed#NASDAQ">REED</a>) fell 12% to $0.0889 after gaining around 35% on Monday.</li>
<li>Otonomy, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/otic#NASDAQ">OTIC</a>) fell 9.6% to $0.1037. Otonomy&#39;s board of directors has approved and adopted a Plan of Liquidation and Dissolution that would include the distribution of remaining cash to stockholders following an orderly wind-down of the company&#39;s operations, including the proceeds from the sale of any pipeline assets.</li>
<li>Hoth Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hoth#NASDAQ">HOTH</a>) fell 9.5% to $2.68 after dropping 14% on Monday. Hoth Therapeutics recently announced submission of investigational new drug application for HT-001.</li>
<li>HTG Molecular Diagnostics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/htgm#NASDAQ">HTGM</a>) shares fell 8.7% to $0.7518 after jumping 49% on Monday.</li>
<li>Sintx Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sint#NASDAQ">SINT</a>) dropped 7% to $7.25. Sintx Technologies announced a 1-for-100 reverse stock split, effective December 20, 2022.</li>
</ul>
Also check this out <a href="https://www.benzinga.com/markets/cryptocurrency/22/12/30145338/ethereum-tops-1-200-chain-becomes-top-loser"> Ethereum Tops $1,200; Chain Becomes Top Loser</a>.

Intraday Update

ACST

AGFY

ALLR

APCX

ATNX

AVYA

AXLA

BIVI

BXRX

CACO

Core Scientific, Inc. - Class A Common Stock

CORZ

COSM

CRKN

DFLI

DUOT

EMBC

EVER

HOTH

HTGM

Hycroft Mining Holding Corporation - Class A Common Stock

HYMC

ICCM

IONR

LABP

LEJU

MGTA

MLGO

MTCR

MUFG

MULN

NEWP

NTCO

OTIC

RCUS

REED

SINT

SLNO

SMFG

SMFL

SRZN

TRDA

UIHC

VIGL

VLON

VRNA

VVOS

WAVD

XCUR

Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session

Ark Restaurants shares are trading lower after the company reported Q4 EPS results were lower year over year.

U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Tuesday. Here are some big stocks recording losses in today&rsquo;s session.
<ul>
<li>Entrada Therapeutics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trda#NASDAQ">TRDA</a>) shares dipped 33.5% to $13.22 after the company said it received a clinical hold notice from the FDA regarding its Investigational New Drug Application for ENTR-601-44 for the potential treatment of Duchenne muscular dystrophy.</li>
<li>Arcus Biosciences, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rcus#NYSE">RCUS</a>) declined 28.1% to $21.92. Gilead Sciences and Arcus Biosciences announced results from the fourth interim analysis of the ARC-7 Phase 2 study for metastatic non-small cell lung cancer with PD-L1 tumor proportion score &ge;50% without epidermal growth factor receptor or anaplastic lymphoma kinase mutations.</li>
<li>BioVie Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bivi#NASDAQ">BIVI</a>) declined 27% to $7.27.</li>
<li>Embecta Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/embc#NASDAQ">EMBC</a>) dropped 14.8% to $27.65 after the company reported a decline in Q4 sales.</li>
<li>Vigil Neuroscience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vigl#NASDAQ">VIGL</a>) dropped 14.5% to $10.51.</li>
<li>Mullen Automotive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/muln#NASDAQ">MULN</a>) declined 14.1% to $0.2330.</li>
<li>FuelCell Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fcel#NASDAQ">FCEL</a>) fell 13.8% to $2.81 after the company reported worse-than-expected Q4 EPS and sales results.</li>
<li>iTeos Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/itos#NASDAQ">ITOS</a>) dropped 13.2% to $17.05.</li>
<li>Ark Restaurants Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arkr#NASDAQ">ARKR</a>) fell 13.1% to $15.74 after the company reported a sharp decline in quarterly earnings.</li>
<li>Summit Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smmt#NASDAQ">SMMT</a>) dropped 12.8% to $3.7707.</li>
<li>Embecta Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/embc#NASDAQ">EMBC</a>) fell 12.4% to $28.47 after the company reported Q4 earnings results.</li>
<li>ioneer Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ionr#NASDAQ">IONR</a>) dropped 12.3% to $11.96.</li>
<li>Terns Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tern#NASDAQ">TERN</a>) fell 10.5% to $8.01 after the company announced a proposed $75 million public offering.</li>
<li>Century Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ipsc#NASDAQ">IPSC</a>) declined 9.5% to $6.31.</li>
<li>Horizon Technology Finance Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hrzn#NASDAQ">HRZN</a>) fell 8.3% to $11.02 after Keefe, Bruyette &amp; Woods downgraded the stock from Market Perform to Underperform and lowered its price target from $11.5 to $10.5.</li>
<li>Sintx Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sint#NASDAQ">SINT</a>) dropped 7% to $7.25. Sintx Technologies announced a 1-for-100 reverse stock split, effective December 20, 2022.</li>
</ul>
Check out this: <a href="https://www.benzinga.com/news/earnings/22/12/30146580/us-stocks-edge-higher-dow-rises-50-points"> US Stocks Edge Higher; Dow Rises 50 Points </a>

FCEL

HRZN

IPSC

ITOS

SMMT

TERN

Arcus Biosciences, FuelCell Energy And Some Other Big Stocks Moving Lower On Tuesday

Ark Restaurants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKR#NASDAQ">ARKR</a>) reported quarterly earnings of $0.21 per share. This is a 88.89 percent decrease over earnings of $1.89 per share from the same period last year. The company reported $46.86 million in sales this quarter. This is a 9.40 percent increase over sales of $42.84 million the same period last year.

Ark Restaurants Q4 EPS $0.21 Down From $1.89 YoY, Sales $46.86M Up From $42.84M YoY

<h3>&nbsp;</h3>
<h3>Companies Reporting After The Bell</h3>
&bull; Ark Restaurants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKR#NASDAQ">ARKR</a>) is expected to report earnings for its fourth quarter.
&bull; Inspirato (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPO#NASDAQ">ISPO</a>) is likely to report quarterly loss at $0.04 per share on revenue of $91.95 million.
&bull; Heico (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HEI#NYSE">HEI</a>) is projected to report quarterly earnings at $0.69 per share on revenue of $602.97 million.
&bull; Steelcase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCS#NYSE">SCS</a>) is expected to report quarterly earnings at $0.18 per share on revenue of $836.42 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

Earnings Scheduled For December 19, 2022

<h3>What is a Value Stock?</h3>
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued. 
<h2>Below is a list of notable value stocks in the consumer cyclical sector:</h2>
<ol>
<li>Ark Restaurants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKR#NASDAQ">ARKR</a>) - P/E: 4.63</li>
<li>Citi Trends (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTRN#NASDAQ">CTRN</a>) - P/E: 3.58</li>
<li>Build-A-Bear Workshop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBW#NYSE">BBW</a>) - P/E: 4.65</li>
<li>WW International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WW#NASDAQ">WW</a>) - P/E: 4.59</li>
<li>LCI Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LCII#NYSE">LCII</a>) - P/E: 5.12</li>
</ol>
Ark Restaurants's earnings per share for Q3 sits at $1.46, whereas in Q2, they were at 0.29. The company's most recent dividend yield sits at 2.36%, which has decreased by 0.66% from 3.02% last quarter. 
Citi Trends saw a decrease in earnings per share from 0.42 in Q1 to $-0.31 now. Its most recent dividend yield is at 1.35%, which has decreased by 0.27% from 1.62% in the previous quarter.
Build-A-Bear Workshop saw a decrease in earnings per share from 0.89 in Q1 to $0.38 now. This quarter, WW International experienced an increase in earnings per share, which was $-0.06 in Q1 and is now $0.4. This quarter, LCI Indus experienced a decrease in earnings per share, which was $7.71 in Q1 and is now $6.06. The company's most recent dividend yield sits at 3.16%, which has decreased by 0.55% from 3.71% last quarter. 
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.

CTRN

LCII

5 Value Stocks To Watch In The Consumer Cyclical Sector

Notable earnings after Monday's close

Ark Restaurants GAAP EPS of $0.38, revenue of $47.48M

Ark Restaurants Corp. (ARKR) Q1 2024 Earnings Call Transcript

Ark Restaurants declares $0.1875 dividend

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Ark Restaurants (NASDAQ:<a href="https://investorplace.com/stock-quotes/arkr-stock-quote/">ARKR</a>) just reported results for the second quarter of 2024.<ul><li>Ark Restaurants reported earnings per share of -40 cents.</li><li>The company reported revenue of $42.26 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/arkr-stock-earnings-ark-restaurants-for-q2-of-2024/">ARKR Stock Earnings: Ark Restaurants Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

ARKR Stock Earnings: Ark Restaurants Reported Results for Q2 2024

Ark Restaurants reports Q2 results

Ark Restaurants Corp. (ARKR) Q2 2024 Earnings Call Transcript

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Ark Restaurants (NASDAQ:<a href="https://investorplace.com/stock-quotes/arkr-stock-quote/">ARKR</a>) just reported results for the third quarter of 2024.<ul><li>Ark Restaurants reported earnings per share of 18 cents.</li><li>The company reported revenue of $50.40 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/arkr-stock-earnings-ark-restaurants-for-q3-of-2024/">ARKR Stock Earnings: Ark Restaurants Reported Results for Q3 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

ARKR Stock Earnings: Ark Restaurants Reported Results for Q3 2024

Ark Restaurants GAAP EPS of $0.18, revenue of $50.4M

Ark Restaurants Corp. (ARKR) Q3 2024 Earnings Call Transcript

ADWPF

ASPN

CETX

CSLLY

DOMA

ELVA

PETV

PREKF

SAFE

SBLK

TWOU

XAIR

Press Releases

Ark Restaurants Announces Conference Call

Ark Restaurants Announces Financial Results for the Fourth Quarter and Fiscal Year Ended 2023

Ark Restaurants Announces Declaration of Dividend

Ark Restaurants Announces Financial Results for the First Quarter of 2024

Comments

Ark Restaurants

Vendite allo scoperto

Ark Restaurants (NASDAQ:ARKR) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO